Cancer screening is the only circumstance in which apparently healthy people subject themselves purposely to an agent known to cause cancer. It is the paradox of mammography, a screening tool that has substantially reduced breast cancer morbidity, whose success has only added to its paradoxical nature.
MIM Software Inc. announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance to market full MIM products running on tablets through thin client technology such as Citrix.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Researchers using contrast-enhanced magnetic resonance imaging (MRI) have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer’s disease (AD), according to a new study published online in the journal Radiology.
The governors of Tennessee and New Hampshire have signed into law measures that establish licensure standards for radiologic technologists in their states.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
CorTechs Labs and Olea Medical announced a partnership agreement to offer NeuroQuant in Olea Sphere, Olea Medical’s suite of imaging applications.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Medic Vision Imaging Solutions Ltd. announced the U.S. Food and Drug Administration (FDA) clearance of SafeCT-29 to help healthcare facilities achieve compliance as mandated by NEMA XR-29 “Smart Dose” standard.
The American College of Radiology (ACR) released eight new and 15 updated Appropriateness Criteria, which define national guidelines for the most appropriate medical imaging exam or radiation therapy.
Vermont Gov. Peter Shumlin signed the Dense Breast Tissue Reporting Senate Bill 157 into law this week, adding to the growing list of density reporting laws across the country.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
May 26, 2016 — Radiation oncologists from across the United States convened on Capitol Hill this week to encourage ...
Check-Cap Ltd. announced that preliminary data from pre-clinical and clinical studies of its ingestible capsule for preparation-free colorectal cancer screening were discussed during Digestive Disease Week (DDW) 2016, May 21-24 in San Diego.
Zebra Medical Vision announced an additional financing round of $12 million led by InterMountain Healthcare, with the participation of existing investors.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Cancer patients at the Carti Cancer Center, Little Rock, Ark., now have access to the latest innovation in diagnostic imaging with Toshiba America Medical Systems Inc.’s Infinix 4-D CT.
vRad (Virtual Radiologic) announced that it ranked No. 19 on 2016’s InformationWeek Elite 100, a list of top business-technology innovators in the United States.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
New Mayo Clinic research suggests that many pancreatic cancer patients whose tumors have grown around the pancreas to encompass critical blood vessels are candidates for surgery, even though conventional wisdom has suggested otherwise.
Positron emission tomography (PET) is used commonly in the diagnosis of suspected lung cancer. Computed bioconductance (CB) id being investigated as a non-invasive way to predict whether an suspicious abnormality in the lung is benign or malignant. In a new study, researchers found that CB combined with PET before biopsy of suspicious lesions could improve diagnostic effectiveness of potentially cancerous lesions detected by computed tomography (CT) scan.
In a new report, Ampronix looks at the rapid expansion of simulated procedures into medical education, including programs recently implemented for Baylor College and Tuoro University System.
Scientists are developing a new photonics device that listens to light and could be capable of detecting skin cancer and other diseases more accurately than ever before, eliminating the need for unnecessary and invasive biopsies.
No one really knows how epiphanies come to be. Those moments of enlightenment, slivers in time, when the curtains are thrown back and there, revealed, is the hardly expected.
Researchers at Haukeland University Hospital in Bergen, Norway, have combined a laboratory ultrasound technique with the commercially-available chemotherapy compound Gemcitabine to increase the porosity of pancreatic cells with microbubbles.